Oxford BioMedica PLC (OXB.L)
18 Jan 2019
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|64||2016||Non-Executive Chairman of the Board|
|56||2008||Chief Executive Officer, Executive Director|
|69||2011||Non-Executive Deputy Chairman of the Board, Senior Independent Director|
|2017||Chief Financial Officer, Director|
- Why are these three shares climbing today?
- Should you buy Blinkx plc, Oxford BioMedica plc and Intelligent Energy Holding plc after today's updates?
- Why Are Lonmin Plc, Oxford BioMedica plc & Bango plc Among Today's Biggest Gainers?
- Are Aminex plc, Premier Oil PLC And Oxford BioMedica plc Set For Strong Recoveries?
- "Buy High, Sell Higher": A Look At Shire plc, ITV plc, Sirius Minerals plc, Betfair Group Ltd & Oxford BioMedica plc
- Should You Buy Oxford BioMedica plc After Novartis AG Deal Sends Shares Surging?